As such, a larger prospective study to assess the relationship between high CD4‐to‐CD8 T cell ratio in otherwise‐healthy, or early‐stage/mild COVID‐19, in middle‐aged and older individuals and severe/fatal COVID‐19 is warranted. The gene discussed is CD8A; the disease is COVID-19.